BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 25817932)

  • 21. Risk of hypoglycemia during hemodialysis in diabetic patients is related to lower pre-dialysis glycemia.
    Burmeister JE; Miltersteiner Dda R; Burmeister BO; Campos JF
    Arch Endocrinol Metab; 2015 Apr; 59(2):137-40. PubMed ID: 25993676
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diabetic nephropathy in hemodialysis patients in Constantine, Algeria.
    Bouhabel A; Saadi N; Bendjeddou J; Laib Z; Hannache K; Aberkane A
    Saudi J Kidney Dis Transpl; 2015 Jan; 26(1):139-40. PubMed ID: 25579737
    [No Abstract]   [Full Text] [Related]  

  • 23. [Regulation of the blood sugar level by the artificial endocrine pancreas (Biostator GCIIS) during dialysis of a diabetic patient].
    Bojta J; Juhász J; Bányai Z; Makó J; Tamás G
    Orv Hetil; 1979 Dec; 120(51):3109-10. PubMed ID: 396497
    [No Abstract]   [Full Text] [Related]  

  • 24. End-stage renal failure and management of diabetes.
    Bilous RW
    Diabet Med; 2004 Jan; 21 Suppl 1():12-4. PubMed ID: 15088931
    [No Abstract]   [Full Text] [Related]  

  • 25. Real-time glucose monitoring in the hospital: future or now?
    Joseph JI; Hipszer B
    Adv Surg; 2010; 44():165-84. PubMed ID: 20919521
    [No Abstract]   [Full Text] [Related]  

  • 26. [Clinical guideline review: Diabetic nephropathies].
    Watanabe T
    Nihon Naika Gakkai Zasshi; 2002 May; 91(5):1537-46. PubMed ID: 12082747
    [No Abstract]   [Full Text] [Related]  

  • 27. Peritoneal dialysis for patients with diabetes and end-stage renal disease: sorting out the biases?
    Finkelstein FO; Smith JD
    ASAIO J; 1996; 42(1):1-3. PubMed ID: 8808447
    [No Abstract]   [Full Text] [Related]  

  • 28. Missed Opportunities for Deprescription: A Teachable Moment.
    Raslan IA; McDonald EG; Lee TC
    JAMA Intern Med; 2017 Jul; 177(7):1028-1029. PubMed ID: 28475657
    [No Abstract]   [Full Text] [Related]  

  • 29. Evaluation and management of diabetic and non-diabetic hypoglycemia in end-stage renal disease.
    Gosmanov AR; Gosmanova EO; Kovesdy CP
    Nephrol Dial Transplant; 2016 Jan; 31(1):8-15. PubMed ID: 26152404
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A case report of osteomyelitis pubis in a hemodialysis patient with diabetes mellitus.
    Dovas S; Liakopoulos V; Simopoulou T; Giannopoulou M; Kanaki A; Anifandis G; Stefanidis I
    Ther Apher Dial; 2008 Oct; 12(5):409-12. PubMed ID: 18937727
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antidiabetic Therapy in End-Stage Renal Disease.
    Boyle SM; Simon B; Kobrin SM
    Semin Dial; 2015; 28(4):337-44. PubMed ID: 25898790
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Japanese society for dialysis therapy clinical guideline for "hemodialysis initiation for maintenance hemodialysis".
    Watanabe Y; Yamagata K; Nishi S; Hirakata H; Hanafusa N; Saito C; Hattori M; Itami N; Komatsu Y; Kawaguchi Y; Tsuruya K; Tsubakihara Y; Suzuki K; Sakai K; Kawanishi H; Inaguma D; Yamamoto H; Takemoto Y; Mori N; Okada K; Hataya H; Akiba T; Iseki K; Tomo T; Masakane I; Akizawa T; Minakuchi J;
    Ther Apher Dial; 2015 Mar; 19 Suppl 1():93-107. PubMed ID: 25817934
    [No Abstract]   [Full Text] [Related]  

  • 33. Japanese society for dialysis therapy clinical guideline for "Maintenance hemodialysis: hemodialysis prescriptions".
    Watanabe Y; Kawanishi H; Suzuki K; Nakai S; Tsuchida K; Tabei K; Akiba T; Masakane I; Takemoto Y; Tomo T; Itami N; Komatsu Y; Hattori M; Mineshima M; Yamashita A; Saito A; Naito H; Hirakata H; Minakuchi J;
    Ther Apher Dial; 2015 Mar; 19 Suppl 1():67-92. PubMed ID: 25817933
    [No Abstract]   [Full Text] [Related]  

  • 34. [Terminal renal insufficiency and diabetes].
    Coronel Díaz F; Naranjo Gómez P; Alvarez Otero MJ; Prats Sánchez D
    Rev Clin Esp; 1983 May; 169(4):221-8. PubMed ID: 6353495
    [No Abstract]   [Full Text] [Related]  

  • 35. [Therapeutic possibilities in patients with terminal kidney insufficiency as a sequela to diabetic nephropathy].
    Jansen JL
    Ned Tijdschr Geneeskd; 1979 Jan; 123(4):117-24. PubMed ID: 368661
    [No Abstract]   [Full Text] [Related]  

  • 36. Management of diabetes in patients with end-stage kidney disease.
    Zuber K
    JAAPA; 2012 Nov; 25(11):26-9. PubMed ID: 23620920
    [No Abstract]   [Full Text] [Related]  

  • 37. Glucose measurement: confounding issues in setting targets for inpatient management: response to Dungan et al.
    Mahoney J; Ellison J
    Diabetes Care; 2007 Jul; 30(7):e71; author reply e72. PubMed ID: 17596494
    [No Abstract]   [Full Text] [Related]  

  • 38. Agents for the treatment of diabetes mellitus.
    O'Mara NB
    Semin Dial; 2010; 23(5):475-9. PubMed ID: 21069919
    [No Abstract]   [Full Text] [Related]  

  • 39. Diabetes mellitus: new approaches to complications.
    Maxwell DR; Luft FC; Clark CM; Vinicor F
    J Indiana State Med Assoc; 1982 Mar; 75(3):184-6. PubMed ID: 7042851
    [No Abstract]   [Full Text] [Related]  

  • 40. A comparison of hemodialysis and transplantation in the treatment of end-stage renal failure secondary to diabetic nephropathy.
    Passer J; Ware F; Steenburg R; Stone DB
    Nebr Med J; 1976 Dec; 61(12):459-63. PubMed ID: 794744
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.